NTS-104

N/A

Report date: 2025/11/28 10:02:01
NME

Base Information

Drug NameNTS-104
Drug Alias NameNTS-104EPRX-01723EIDD-1723NTS-1104(Emory University)
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor agonists
TargetsProgesterone receptor
Therapy Area/IndicationsIschemic StrokeHematoma, Subdural, ChronicBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEmory University
China Registration ClassN/A

Develop Information

Active CompaniesNeuroTrauma Sciences LLC
Inactive CompaniesN/A
Active IndicationsIschemic StrokeHematoma, Subdural, ChronicBrain Injuries, Traumatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A